Skip to main content
Caplight Logo









Bitterroot Bio

Bitterroot Bio

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://brbio.com/

Last Round

Series A

Jun 7, 2023

Total Funding Raised

$145M

Company Overview

Bitterroot Bio is a biotechnology company that develops novel immunotherapies for the treatment of cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cardio-immunologybiotechnologycardiovascular diseasedrug developmenttherapeutic pipelinedrug discoverybiotech startupclinical-stage biotechimmune pathwaysheart medicineCD47drug licensingpreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bitterroot Bio Comparables

Compare Bitterroot Bio with similar companies based on industry and business-model similarity.

Bitterroot Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cardurion Pharmaceuticals
84%
POLYGON Therapeutics
84%
Cyclarity Therapeutics
83%

Bitterroot Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 7, 2023

Key People

Founding team and executive leadership

Pavan Cheruvu

CEO

Executive Team

Bitterroot Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2025

    Phase 1 results for BRB-002 to be presented at ACC 2025.

  • Mar 17, 2025

    Will present at the American College of Cardiology Annual Scientific Session 2025.

Bitterroot Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bitterroot Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bitterroot Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range28
Year Founded2021
Last FundingJun 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?